JPMorgan Downgrades United Therapeutics Corp. (UTHR) to Underweight
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $499.73 -0.31%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Neutral to Underweight with a price target of $40.00 (from $50.00) following CRL from FDA for Oral Treprostinil.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.28 yesterday.
For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $53.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Wedbush Downgrades Globant S.A. (GLOB) to Neutral on balanced risk/reward
- Citizens Downgrades Accelerant Holdings (ARX) to Market Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
